<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03494582</url>
  </required_header>
  <id_info>
    <org_study_id>AVVCP</org_study_id>
    <nct_id>NCT03494582</nct_id>
  </id_info>
  <brief_title>Abdominal Versus Vaginal Hysteropexy</brief_title>
  <official_title>Trans Vaginal Sacrospinous Hysteropexy Versus Abdominal Sacral Hysteropexy for the Management of Uterine Prolapse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the vaginal versus the abdominal approach for the management of
      uterine prolapse
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      this study compares The unilateral sacrospinous hysteropexy with prolene sutures versus the
      abdominal sacral hysteropexy using Mersilene suture for the management of uterine prolapse
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pelvic organ prolapse quantification system</measure>
    <time_frame>3 month</time_frame>
    <description>compare Pelvic organ prolapse quantification system between groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative data</measure>
    <time_frame>1 day</time_frame>
    <description>operative time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>operative details</measure>
    <time_frame>1 day</time_frame>
    <description>blood loss</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Uterine Prolapse</condition>
  <arm_group>
    <arm_group_label>Sacral Hysteropexy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Abdominal approach for uterine suspension</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sacrospinous Hysteropexy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transvaginal approach for uterine suspension</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sacral Hysteropexy</intervention_name>
    <description>Abdominal approach for uterine suspension</description>
    <arm_group_label>Sacral Hysteropexy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sacrospinous Hysteropexy</intervention_name>
    <description>Transvaginal approach for uterine suspension</description>
    <arm_group_label>sacrospinous Hysteropexy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Uterine Prolapse

        Exclusion Criteria:

          -  Previous prolapse surgery Hereditary Connective tissue disorders
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hamdy HA Ahmed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hamdy HA Ahmed, MD</last_name>
    <phone>00201222815141</phone>
    <email>hamdytheproff@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Urogynecology Unit</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hamdy AH saaid, MD</last_name>
      <phone>+201112422276</phone>
      <email>drhamdytheproff@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2018</study_first_submitted>
  <study_first_submitted_qc>April 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2018</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>Hamdy Ahmed Saaid</investigator_full_name>
    <investigator_title>Fellow of OBS/GYN</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Uterine Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

